Marché de la nutrition médicale entérale – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00029582
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 306
Buy Now

Le marché de la nutrition médicale entérale devrait atteindre 11 726,37 millions de dollars d'ici 2028 à partir de 7 803,45 millions de dollars en 2021 ; il devrait croître à un TCAC de 6,0 % de 2022 à 2028.



La nutrition entérale (EN) est fournie aux patients dont les besoins énergétiques et nutritionnels ne peuvent être satisfaits par un apport alimentaire régulier. Les avantages de la prise entérale par rapport à la nutrition parentérale sont bien connus. Pour la plupart des patients pédiatriques qui dépendent de la nutrition entérale, une formule polymère standard adaptée à l'âge et enrichie en fibres est un choix approprié.



Le Le marché de la nutrition médicale entérale est segmenté en fonction de l'indication, du type de nutrition, de la forme, du produit, du canal de distribution, du groupe d'âge et de la géographie. Par géographie, le marché est largement segmenté en Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient & Afrique et Sud & Amérique centrale. Le rapport offre des informations et une analyse approfondie du marché, en mettant l'accent sur des paramètres tels que les tendances et la dynamique du marché, ainsi que sur l'analyse concurrentielle des principaux acteurs du marché mondial. 



Insights stratégiques



Régions lucratives pour le marché de la nutrition médicale entérale



Régions lucratives pour le marché de la nutrition médicale entérale Aperçu du marché



Augmentation de la prévalence de Cachexie



La cachexie est une maladie multifonctionnelle qui provoque une perte de poids extrême, une perte de muscle squelettique et de tissu adipeux, un déséquilibre de la régulation métabolique et une réduction de l'apport alimentaire. C'est une conséquence clinique grave de presque toutes les maladies chroniques lorsqu'elles atteignent des stades avancés. Selon le NCBI (National Center for Biotechnology Information), en 2016, la prévalence de la cachexie variait de 5 à 15 % dans l'insuffisance cardiaque chronique en phase terminale. Elle survient fréquemment chez les patients souffrant d'insuffisance rénale chronique, maladie pulmonaire obstructive chronique (MPOC) , maladie neurologique et polyarthrite rhumatoïde. Les taux de mortalité des patients atteints de cachexie varient de 15 à 25 % par an chez les patients atteints de BPCO sévère et de 20 à 40 % par an chez les patients souffrant d'insuffisance cardiaque chronique ou de maladie rénale chronique.



< p>La cachexie cancéreuse affecte négativement la qualité de vie des patients atteints de cancer et réduit l'efficacité de la chimiothérapie anticancéreuse et augmente sa toxicité, entraînant une augmentation de la mortalité liée au cancer et des dépenses en ressources médicales. Selon le Globocan, l'Organisation mondiale de la santé a signalé 9,6 millions de décès et 18,1 millions de nouveaux cas de cancer en 2018. De plus, la cachexie cancéreuse est un syndrome de dépérissement qui survient chez jusqu'à 80 % des patients atteints de cancer. Selon l'article publié par le Département de médecine pulmonaire et de soins intensifs de Pékin, la prévalence de la cachexie est de 87 % chez les patients atteints d'un cancer du pancréas et de l'estomac ; 61 % chez les patients atteints d'un cancer du côlon, du poumon et de la prostate ; et ~ 40 % chez les patients atteints de cancer du sein, de sarcome, de leucémie et de lymphome hodgkinien. De plus, 20 % du total des décès liés au cancer sont dus à la cachexie. Dans la cachexie, les nutriments dans le corps diminuent. Par conséquent, il est nécessaire de fournir des nutriments externes pour poursuivre le traitement du cancer et de la MPOC. Les médecins préfèrent la voie entérale pour fournir ces nutriments nécessaires au patient. Par conséquent, la prévalence croissante de la cachexie due à l'incidence croissante de diverses maladies chroniques alimente la croissance du marché de la nutrition médicale entérale. 



Indication Insights



Sur la base des indications, le marché de la nutrition médicale entérale est segmenté en troubles respiratoires, cancer, post COVID-19, troubles gastro-intestinaux, insuffisance hépatique et autres. Le marché du segment des troubles respiratoires est en outre segmenté en maladie pulmonaire obstructive chronique (MPOC), insuffisance respiratoire, fibrose kystique et autres. Le marché du segment du cancer est sous-segmenté en cachexie cancéreuse, cachexie avec BPCO et autres. Le marché du segment des troubles gastro-intestinaux est en outre segmenté en occlusion intestinale, occlusion intestinale courte, maladie de Crohn et autres. Le segment des troubles respiratoires détenait la plus grande part de marché en 2021. Cependant, le segment du cancer devrait enregistrer le TCAC le plus élevé de 7,6 % sur le marché au cours de la période de prévision. Pulmocare fabriqué par Abbott est conçu pour les personnes souffrant de MPOC, de fibrose kystique ou d'insuffisance respiratoire. Glucides et lipides modifiés riches en caloriesformule entérale peut aider ces patients à réduire la production de dioxyde de carbone induite par l'alimentation.



Marché de la nutrition médicale entérale, par indication - 2022 et 2028< /h3>

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the enteral medical nutrition market?

Enteral nutrition refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver nutrition and calories. It can include a normal oral diet, the use of liquid supplements, or delivery by use of a tube (tube feeding). According to the American College of Gastroenterology, there are six main types of feeding tubes. These tubes may have further subtypes depending on exactly where they end in the stomach or intestines.

What are the driving factors for the enteral medical nutrition market across the country?

Factors such as the prevalence of cachexia and the rise in the prevalence of gastrointestinal diseases drive the market growth. However, the complications associated with enteral medical nutrition hamper the growth of the market.

Who are the major players in market the enteral medical nutrition market?

The enteral medical nutrition market majorly consists of the players such as Abbott Laboratories; Nutricia; Fresenius Kabi AG; B. Braun Melsungen AG; NESTLE S.A.; Meiji Holdings Co., Ltd.; Smartfish AS; DSM; Hormel Foods Corporation; and Global Health Products, Inc.

Which segment is dominating the enteral medical nutrition market?

The global enteral medical nutrition market based on indication, is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, others. The respiratory disorders segment held the largest share of the market in 2021. However, the cancer segment is expected to register the highest CAGR during the forecast period.

The List of Companies - Enteral Medical Nutrition Market

  1. Abbott Laboratories  
  2. Nutricia  
  3. Fresenius Kabi AG
  4.  B. Braun Melsungen AG  
  5. NESTLE S.A.  
  6. Meiji Holdings Co., Ltd.  
  7. Smartfish AS  
  8. DSM  
  9. Hormel Foods Corporation
  10. Global Health Products, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports